📊 Score Breakdown
Offering Ability
90
Cash Runway
25
Float Risk
57
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
43%
🔄 Reverse Split
55%
• 50-day avg $0.36 below $1 exchange minimum
📉 Score Deterioration
40%
• Score rose 32 points recently (worsening)
💰 Capital Raise
20%
• Active shelf registration ($100M, 900% of market cap)
💹 Market Data
Market Cap$11.12M
Shares Outstanding43.42M
Float16.59M
Cash$3.79M
Debt$5.32M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 53.0% shares (2025Q4 vs prior)
12 institutional holders · 639.0K shares
#1
VANGUARD GROUP INC
248.9K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
132.6K shares
#3
Yorkville Advisors Global, LP
131.9K shares
+ 9 more holders Sign up free to view →
📉 Short Interest
Short Interest87.8K
Days to Cover1.2
% of Float0.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Oct 27, 2025
xbrl
XBRL WARRANT
Jun 22, 2025
EFFECT
EFFECT
Apr 24, 2026
S-3
SHELF
Apr 16, 2026
8-K
8K EVENT
Feb 20, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for JUNS
📊 JUNS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 JUNS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.